ACUR (Acura Pharmaceuticals) Cyclically Adjusted PB Ratio: (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ACUR Acura Pharmaceuticals Inc ACUR
16 GF Score
Price $0.00
View Full Analysis

What is Acura Pharmaceuticals Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Acura Pharmaceuticals  (OTCPK:ACUR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Acura Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms


Acura Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Acura Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acura Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Acura Pharmaceuticals Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Acura Pharmaceuticals Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ACUR vs VFRM, THCT, CBGL: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Acura Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acura Pharmaceuticals Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Acura Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Acura Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


ACUR
16GF Score
Acura Pharmaceuticals Inc ACUR
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acura Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Acura Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2021 is calculated as:

For example, Acura Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Dec. 2021 was:

Adj_Book=Book Value per Share/CPI of Dec. 2021 (Change)*Current CPI (Dec. 2021)
=0.003/278.8020*278.8020
=0.003

Current CPI (Dec. 2021) = 278.8020.

Acura Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201203 3.674 229.392 4.465
201206 3.482 229.478 4.230
201209 3.295 231.407 3.970
201212 3.012 229.601 3.657
201303 2.487 232.773 2.979
201306 2.196 233.504 2.622
201309 2.136 234.149 2.543
201312 1.854 233.049 2.218
201403 1.386 236.293 1.635
201406 1.054 238.343 1.233
201409 0.776 238.031 0.909
201412 0.517 234.812 0.614
201503 0.666 236.119 0.786
201506 0.426 238.638 0.498
201509 0.739 237.945 0.866
201512 0.669 236.525 0.789
201603 0.402 238.132 0.471
201606 0.138 241.018 0.160
201609 -0.041 241.428 -0.047
201612 0.100 241.432 0.115
201703 0.144 243.801 0.165
201706 -0.027 244.955 -0.031
201709 0.077 246.819 0.087
201712 -0.001 246.524 -0.001
201803 -0.068 249.554 -0.076
201806 -0.125 251.989 -0.138
201809 -0.174 252.439 -0.192
201812 -0.172 251.233 -0.191
201903 -0.205 254.202 -0.225
201906 -0.242 256.143 -0.263
201909 -0.231 256.759 -0.251
201912 -0.223 256.974 -0.242
202003 -0.245 258.115 -0.265
202006 -0.230 257.797 -0.249
202009 -0.261 260.280 -0.280
202012 -0.272 260.474 -0.291
202103 -0.278 264.877 -0.293
202106 0.006 271.696 0.006
202109 0.002 274.310 0.002
202112 0.003 278.802 0.003

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Acura Pharmaceuticals Business Description

Address 616 N. North Court, Suite 120, Palatine, IL, USA, 60067
Acura Pharmaceuticals Inc is a drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications. It has discovered and developed three proprietary platform technologies which can be used to develop multiple products. Its Limitx Technology is being developed to minimize the risk of overdose, its Aversion Technology is intended to address methods of abuse associated with opioid analgesics while its Impede Technology is directed at minimizing the extraction and conversion of pseudoephedrine, or PSE, into methamphetamine. It operates in single segment being the research, development and commercialization of technologies and products intended to address safe use of medications.
16GF Score

Get the complete analysis for ACUR

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price